RESEARCH TRIANGLE PARK, N.C., Dec. 13, 2022 -- Pappas Capital, a global venture capital and commercial development firm, announced today the appointment of Richard Staub as Venture Partner. His appointment...
Cognetix explored the use of snail toxins for the treatment of epilepsy, pain and anesthesia.
Salt Lake City, UT
© 2022 Pappas Capital, LLC. ALL RIGHTS RESERVED.